Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry

Analytical Chemistry

Volumn 83, Issue 12, 2011, Pages 4729-4737

  Pierce, Carrie L ^a   Williams, Tracie L ^a   Moura, Hercules ^a   Pirkle, James L ^a   Cox, Nancy J ^b   Stevens, James ^b   Donis, Ruben O ^b   Barr, John R ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY AND PRECISION; ANTIBODY-ANTIGEN; IMMUNOAFFINITY; IMMUNODIFFUSION; INFLUENZA VACCINES; ISOTOPE DILUTION MASS SPECTROMETRY; ISOTOPE DILUTIONS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; MATRIX PROTEINS; NEURAMINIDASE; POLYCLONAL ANTIBODY; TRYPTIC PEPTIDES; VIRAL PROTEINS;

ANTIGEN-ANTIBODY REACTIONS; ISOTOPES; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; NUCLEIC ACIDS; PURIFICATION; VIRUSES;

ANTIBODIES;

INFLUENZA VIRUS HEMAGGLUTININ; MATRIX PROTEIN; NUCLEOPROTEIN; PEPTIDE; SIALIDASE; VIRUS ANTIBODY;

ARTICLE; ENZYMOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H3N2; ISOTOPE LABELING; METABOLISM; METHODOLOGY; TANDEM MASS SPECTROMETRY; VIROLOGY;

ANTIBODIES, VIRAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; ISOTOPE LABELING; NEURAMINIDASE; NUCLEOPROTEINS; PEPTIDES; TANDEM MASS SPECTROMETRY; VIRAL MATRIX PROTEINS;

EID: 79959253885     PISSN: 00032700     EISSN: None     Source Type: Journal    
DOI: 10.1021/ac2006526     Document Type: Article

References (27)

1. Bright, R. A.; Carter, D. M.; Daniluk, S.; Toapanta, F. R.; Ahmad, A.; Gavrilov, V.; Massare, M.; Pushko, P.; Mytle, N.; Rowe, T.; Smith, G.; Ross, T. M. Vaccine 2007, 25, 3871-3878
2. Wood, J. M.; Schild, G. C.; Newman, R. W.; Seagroatt, V. J. Biol. Stand. 1977, 5, 237-247
3. Wood, J. M.; Schild, G. C.; Newman, R. W.; Seagroatt, V. Dev. Biol. Stand. 1977, 39, 193-200
4. Mostow, S. R.; Schild, G. C.; Dowdle, W. R.; Wood, R. J. J. Clin. Microbiol. 1975, 2, 531-540
5. Schild, G. C.; Pereira, M. S.; Chakraverty, P. Bull. World Health Org. 1975, 52, 43-50
6. Williams, T. L.; Luna, L.; Guo, Z.; Cox, N. J.; Pirkle, J. L.; Donis, R. O.; Barr, J. R. Vaccine 2008, 26, 2510-2520
7. Feng, J.; Gulati, U.; Zhang, X.; Keitel, W. A.; Thompson, D. M.; James, J. A.; Thompson, L. F.; Air, G. M. Vaccine 2009, 27, 6358-6362
8. Barr, J. R.; Maggio, V. L.; Patterson, D. G., Jr.; Cooper, G. R.; Henderson, L. O.; Turner, W. E.; Smith, S. J.; Hannon, W. H.; Needham, L. L.; Sampson, E. J. Clin. Chem. 1996, 42, 1676-1682
9. Boyer, A. E.; Quinn, C. P.; Hoffmaster, A. R.; Kozel, T. R.; Saile, E.; Marston, C. K.; Percival, A.; Plikaytis, B. D.; Woolfitt, A. R.; Gallegos, M.; Sabourin, P.; McWilliams, L. G.; Pirkle, J. L.; Barr, J. R. Infect. Immun. 2009, 77, 3432-3441
10. Kalb, S. R.; Moura, H.; Boyer, A. E.; McWilliams, L. G.; Pirkle, J. L.; Barr, J. R. Anal. Biochem. 2006, 351, 84-92
11. Kalb, S. R.; Lou, J.; Garcia-Rodriguez, C.; Geren, I. N.; Smith, T. J.; Moura, H.; Marks, J. D.; Smith, L. A.; Pirkle, J. L.; Barr, J. R. PLoS One 2009, 4, e5355
12. Kalb, S. R.; Barr, J. R. Anal. Chem. 2009, 81, 2037-2042
13. Boyer, A. E.; Quinn, C. P.; Woolfitt, A. R.; Pirkle, J. L.; McWilliams, L. G.; Stamey, K. L.; Bagarozzi, D. A.; Hart, J. C., Jr.; Barr, J. R. Anal. Chem. 2007, 79, 8463-8470
14. Mayya, V.; D, K. H. Expert Rev. Proteomics 2006, 3, 597-610
15. Bronstrup, M. Expert Rev. Proteomics 2004, 1, 503-512
16. Woolfitt, A. R.; Solano, M. I.; Williams, T. L.; Pirkle, J. L.; Barr, J. R. Anal. Chem. 2009, 81, 3979-3985
17. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research; Influenza Virus Vaccine Potency Reagents for Single-Radial-Immunodiffusion; A/Wisconsin/67/2005 X-161b; CBER Ref. #55. Rockville, MD, 2006.
18. Bruhl, P.; Kerschbaum, A.; Kistner, O.; Barrett, N.; Dorner, F.; Gerencer, M. Vaccine 2000, 19, 1149-1158
19. Yu, Y. Q.; Gilar, M.; Lee, P. J.; Bouvier, E. S.; Gebler, J. C. Anal. Chem. 2003, 75, 6023-6028
20. Suder, P.; Bierczynska, A.; Konig, S.; Silberring, J. Rapid Commun. Mass Spectrom. 2004, 18, 822-824
21. Laver, W. G.; Valentine, R. C. Virology 1969, 38, 105-119
22. Remeta, D. P.; Krumbiegel, M.; Minetti, C. A.; Puri, A.; Ginsburg, A.; Blumenthal, R. Biochemistry 2002, 41, 2044-2054
23. Ruigrok, R. W.; Martin, S. R.; Wharton, S. A.; Skehel, J. J.; Bayley, P. M.; Wiley, D. C. Virology 1986, 155, 484-497
24. Johannsen, R.; Moser, H.; Hinz, J.; Friesen, H. J.; Gruschkau, H. J. Biol. Stand. 1983, 11, 341-352
25. Williams, M. S. Vet. Microbiol. 1993, 37, 253-262
26. World Health Organization; National Institute for Biological Standards and Control (NIBSC); Influenza Reagent Antigen Reagent for Single-Radial- Diffusion Assay of A/Wisconsin/67/2005 (H3N2) (NYMCX-161-B). NIBSC code: 06/120, Instructions for use (Version 3.0, Dated 09/07/2007). Hertfordshite, UK. 2007, 1-2.
27. Wood, J. M. Philos. Trans. R. Soc. London, B: Biol. Sci. 2001, 356, 1953-1960